about
SATB2 augments ΔNp63α in head and neck squamous cell carcinomaOncogenic Intra-p53 Family Member Interactions in Human CancersNovel Implications of DNA Damage Response in Drug Resistance of Malignant Cancers Obtained from the Functional Interaction between p53 Family and RUNX2Structural Basis for ASPP2 Recognition by the Tumor Suppressor p73Gain of function of mutant p53: R282W on the peak?ΔNp63α and microRNAs: leveraging the epithelial-mesenchymal transitionThe Regulation of Tumor Suppressor p63 by the Ubiquitin-Proteasome SystemNuclear actions of insulin-like growth factor binding protein-3The microRNA feedback regulation of p63 in cancer progressionp73 as a pharmaceutical target for cancer therapyDysregulated ΔNp63α inhibits expression of Ink4a/arf, blocks senescence, and promotes malignant conversion of keratinocytesAssociations between p53 overexpression and multiple measures of clinical outcome in high-risk, early stage or suboptimally-resected, advanced stage epithelial ovarian cancers A Gynecologic Oncology Group study.A microRNA-dependent program controls p53-independent survival and chemosensitivity in human and murine squamous cell carcinoma.A planarian p53 homolog regulates proliferation and self-renewal in adult stem cell lineagesQuercetin abrogates chemoresistance in melanoma cells by modulating deltaNp73.Targeting p53 for Novel Anticancer Therapy.C/EBPδ gene targets in human keratinocytes.CK2 modulation of NF-kappaB, TP53, and the malignant phenotype in head and neck cancer by anti-CK2 oligonucleotides in vitro or in vivo via sub-50-nm nanocapsules.Loss of p73 promotes dissemination of Myc-induced B cell lymphomas in miceGenome-wide mapping indicates that p73 and p63 co-occupy target sites and have similar dna-binding profiles in vivo.DeltaNp63alpha-mediated induction of epidermal growth factor receptor promotes pancreatic cancer cell growth and chemoresistanceTracing the protectors path from the germ line to the genome.The role of mutant p53 in human cancer.DEK promotes HPV-positive and -negative head and neck cancer cell proliferation.ΔNp63 promotes stem cell activity in mammary gland development and basal-like breast cancer by enhancing Fzd7 expression and Wnt signalling.Ceramide modulates pre-mRNA splicing to restore the expression of wild-type tumor suppressor p53 in deletion-mutant cancer cells.CK2 phosphorylates and inhibits TAp73 tumor suppressor function to promote expression of cancer stem cell genes and phenotype in head and neck cancer.The chromosomal instability pathway in colon cancerTAp73 induction by nitric oxide: regulation by checkpoint kinase 1 (CHK1) and protection against apoptosis.p63 attenuates epithelial to mesenchymal potential in an experimental prostate cell model.Distinct expression profiles of p63 variants during urothelial development and bladder cancer progressionP53 family members modulate the expression of PRODH, but not PRODH2, via intronic p53 response elements.p63 maintains keratinocyte proliferative capacity through regulation of Skp2-p130 levels.ΔNP63α transcriptionally activates chemokine receptor 4 (CXCR4) expression to regulate breast cancer stem cell activity and chemotaxisMutant p53 protein is targeted by arsenic for degradation and plays a role in arsenic-mediated growth suppression.The p73 tumor suppressor is targeted by Pirh2 RING finger E3 ubiquitin ligase for the proteasome-dependent degradation.Induction of apoptotic genes by a p73-phosphatase and tensin homolog (p73-PTEN) protein complex in response to genotoxic stress.TNF-α promotes c-REL/ΔNp63α interaction and TAp73 dissociation from key genes that mediate growth arrest and apoptosis in head and neck cancerRegulation of p73 activity by post-translational modifications.The p53 family member p73 modulates the proproliferative role of IGFBP3 in short children born small for gestational age
P2860
Q24299322-F03F092B-E196-4BAF-8F4F-F42184F98DCBQ26749382-7266475B-A46F-4299-87A3-925146BD0720Q26777988-8C6428AC-21A9-4B4B-ADC3-CD819A14F17DQ27671671-8067C051-0698-4FA9-B33E-9A56D4E6CB05Q28068551-9E48BA92-6048-4FC1-81DC-4433263325EBQ28077508-B1B87347-FC6D-43B0-9617-3EBA1BB02607Q28078288-2137CDBC-048D-4A95-AA7B-002449D6FF4AQ28080513-6FD874AB-EBB5-41C8-B539-856CD7F972E2Q28084646-F5455EAE-617C-4BEF-8309-DAF1AB37C678Q28611414-7C78970E-45D8-436B-99AB-B50404FE0EBCQ28742570-2D3C252A-E926-456B-834C-3666DA5E6EF6Q30437752-A6C7D53A-9E27-4081-87BE-D5605918696AQ30497990-BBADF558-F358-4B39-9449-1B36C1EF1560Q33561621-C5568A98-C6CB-466E-854B-D879BF2B6A90Q33601945-26303534-369D-4927-BBFC-0FB5934A4C34Q33655329-6768F030-B8C7-44C7-84A5-975008EE4889Q33745060-AC900560-C90F-41B3-84B4-0E9BBC2D27F2Q33817704-7E3C521C-AA8A-47AD-BE3E-8A57B77BF890Q33882866-78416073-6996-4042-BCFB-84C83DC86E13Q33996178-C0ECFD72-D566-419B-BABC-B747496F4D75Q34067050-59CFF423-B563-4CFE-96AA-5E94BC3E8FBEQ34100529-7DB50C1D-EC2D-4283-9545-5750152C36A0Q34153014-61A4ECD2-8405-463B-9639-648C0A70E7C3Q34161127-9EDCA95F-9D17-49C6-A7A0-F44AAEB36C72Q34283057-DEF0114B-B38F-4964-BF82-76ED5210EB24Q34302149-335A7E8C-646A-4C4F-BD8D-FA6D6F80D2FAQ34417563-6C4BFDBA-7557-40B2-B59D-3F7A986E63E4Q34570062-0271970D-9BF9-4E26-9606-A466E8F19435Q34624156-7AB9FF59-2149-4ECC-B7A7-8D6EE29A14FBQ34712604-FD4F4824-986A-4428-9A0F-1BC0BD18902DQ34755858-7F2DA26C-400F-4B4D-A048-FB2F51121C10Q34828404-51DBBF87-B073-4C98-A66D-6FB50D893428Q34897562-353D54B6-223C-4546-9BD3-4F7BE6D2EAF5Q34978368-E382CB48-11AD-46F2-9DCA-B9DD9B3A5474Q34978872-73FAC0B1-D3F9-4813-9A2C-DCC2E50F0889Q35371834-EB940E9A-4EA7-46DC-BA97-F7702112751AQ35379204-200943A7-4048-4A8F-A8B4-BDB0F0268CC9Q35501271-C2C6BDC6-63CE-40C9-91F1-1B8D3F714EFAQ35865249-90BF7DD9-0E9E-458D-A735-5D0EE1AD2D72Q36063747-ACB7BB7A-7423-4431-8A7C-F43BF6BF8276
P2860
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
p63 and p73 in human cancer: defining the network.
@en
type
label
p63 and p73 in human cancer: defining the network.
@en
prefLabel
p63 and p73 in human cancer: defining the network.
@en
P2860
P356
P1433
P1476
p63 and p73 in human cancer: defining the network.
@en
P2093
L W Ellisen
M P Deyoung
P2860
P2888
P304
P356
10.1038/SJ.ONC.1210337
P407
P577
2007-03-05T00:00:00Z